{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:13:49Z","timestamp":1791112429835,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T00:00:00Z","timestamp":1229472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s11883-009-0007-9","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T18:46:43Z","timestamp":1229453203000},"page":"45-51","source":"Crossref","is-referenced-by-count":29,"title":["Niacin: An old drug rejuvenated"],"prefix":"10.1007","volume":"11","author":[{"given":"Vaijinath S.","family":"Kamanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha H.","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti L.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,17]]},"reference":[{"key":"7_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","volume":"54","author":"R. Altschul","year":"1955","unstructured":"Altschul R, Hoffer A, Stephen JD: Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys 1955, 54:558\u2013559.","journal-title":"Arch Biochem Biophys"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","volume":"15","author":"C.D. Meyers","year":"2004","unstructured":"Meyers CD, Kamanna VS, Kashyap ML: Niacin therapy in atherosclerosis. Curr Opin Lipidol 2004, 15:659\u2013665.","journal-title":"Curr Opin Lipidol"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","volume":"258","author":"L.A. Carlson","year":"2005","unstructured":"Carlson LA: Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005, 258:94\u2013114.","journal-title":"J Intern Med"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/17460875.1.5.549","volume":"1","author":"S.H. Ganji","year":"2006","unstructured":"Ganji SH, Zhang LH, Kamanna VS, Kashyap ML: Effect of niacin on lipoproteins and atherosclerosis. Future Lipidol 2006, 1:549\u2013557.","journal-title":"Future Lipidol"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0002-9149(03)00394-1","volume":"91","author":"J.M. Morgan","year":"2003","unstructured":"Morgan JM, Capuzzi DM, Baksh RI: Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol 2003, 91:1432\u20131436.","journal-title":"Am J Cardiol"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/01.CIR.99.15.1959","volume":"99","author":"A. Zambon","year":"1999","unstructured":"Zambon A, Hokanson JE, Brown BG, et al.: Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 1999, 99:1959\u20131964.","journal-title":"Circulation"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1345\/aph.1E322","volume":"39","author":"J.M. Backes","year":"2005","unstructured":"Backes JM, Gibson CA: Effect of lipid lowering drug therapy on small-dense low-density lipoprotein. Ann Pharmacother 2005, 39:523\u2013526.","journal-title":"Ann Pharmacother"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9149(01)01639-3","volume":"88","author":"J.M. McKenney","year":"2001","unstructured":"McKenney JM, McCormick LS, Schaefer EJ, et al.: Effect of niacin and atrovastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. Am J Cardiol 2001, 88:270\u2013274.","journal-title":"Am J Cardiol"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2796.1990.tb00209.x","volume":"228","author":"G. Wahlberg","year":"1990","unstructured":"Wahlberg G, Walldius G, Olsson AG, et al.: Effect of nicotinic acid on serum cholesterol concentrations of high density lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemia. J Intern Med 1990, 228:151\u2013157.","journal-title":"J Intern Med"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1185\/030079905X43677","volume":"21","author":"J. Shepherd","year":"2005","unstructured":"Shepherd J, Betteridge J, Van Gaal L, European Consensus Panel: Nicotinic acid in the management of dyslipidemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Curr Med Res Opin 2005, 21:665\u2013682.","journal-title":"Curr Med Res Opin"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/hq1001.096624","volume":"21","author":"T. Sakai","year":"2001","unstructured":"Sakai T, Kamanna VS, Kashyap ML: Niacin but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol. Arterioscler Thromb Vasc Biol 2001, 21:1783\u20131789.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","volume":"345","author":"B.G. Brown","year":"2001","unstructured":"Brown BG, Zhao XQ, Chait A, et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583\u20131592.","journal-title":"N Engl J Med"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","volume":"110","author":"A.J. Taylor","year":"2004","unstructured":"Taylor AJ, Sullenberger LE, Lee HJ, et al.: Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER)2. Circulation 2004, 110:3512\u20133517.","journal-title":"Circulation"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"C1773","DOI":"10.1152\/ajpcell.00409.2007","volume":"293","author":"H.M. Said","year":"2007","unstructured":"Said HM, Nabokina SM, Balamurgan K, et al.: Mechanism of nicotinic acid transport in human liver cells: experiments with HepG2 cells and primary hepatocytes. Am J Physiol Cell Physiol 2007, 293:C1773\u2013C1778.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"C97","DOI":"10.1152\/ajpcell.00009.2005","volume":"289","author":"S.M. Nabokina","year":"2005","unstructured":"Nabokina SM, Kashyap ML, Said HM: Mechanism and regulation of human intestinal niacin uptake. Am J Physiol Cell Physiol 2005, 289:C97\u2013C103.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00041433-199510000-00006","volume":"6","author":"H.N. Ginsberg","year":"1995","unstructured":"Ginsberg HN: Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol 1995, 6:275\u2013280.","journal-title":"Curr Opin Lipidol"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(99)00083-9","volume":"1440","author":"R.A. Davis","year":"1999","unstructured":"Davis RA: Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim Biophys Acta 1999, 1440:1\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-2275(20)34737-4","volume":"22","author":"S.M. Grundy","year":"1981","unstructured":"Grundy SM, Mok HY, Zech L, et al.: Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 1981, 22:24\u201336.","journal-title":"J Lipid Res"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.19.4.1051","volume":"19","author":"F.Y. Jin","year":"1999","unstructured":"Jin FY, Kamanna VS, Kashyap ML: Niacin accelerates intracellular apo B degradaqtion by inhibiting triacylglycerol synthesis in human hepatoblastoma (Hep G2) cells. Arterioscler Thromb Vasc Biol 1999, 19:1051\u20131059.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","volume":"45","author":"S.H. Ganji","year":"2004","unstructured":"Ganji SH, Tavintharan S, Zhu D, et al.: Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. J Lipid Res 2004, 45:1835\u20131845.","journal-title":"J Lipid Res"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.0954-6820.1962.tb07203.x","volume":"172","author":"L.A. Carlson","year":"1962","unstructured":"Carlson LA, Oro L: The effect of nicotinic acid on the plasma free fatty acids. Acta Med Scand 1962, 172:641\u2013645.","journal-title":"Acta Med Scand"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0954-6820.1963.tb17457.x","volume":"173","author":"L.A. Carlson","year":"1963","unstructured":"Carlson LA: Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro. Acta Med Scand 1963, 173:719\u2013722.","journal-title":"Acta Med Scand"},{"key":"7_CR23","first-page":"II","volume":"116","author":"E. Lai","year":"2007","unstructured":"Lai E, Waters G, Tata J, et al.: A niacin receptor partial agonist, MK-0354, robustly reduces plasma free fatty acids and produces little flushing but fails to alter LDL-C, HDL-C, and triglycerides in humans. Circulation 2007, 116:II\u201316A.","journal-title":"Circulation"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.20783","volume":"42","author":"X.X. Yu","year":"2005","unstructured":"Yu XX, Murray SF, Pandey SK, et al.: Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005, 42:362\u2013371.","journal-title":"Hepatology"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1172\/JCI108833","volume":"60","author":"C.B. Blum","year":"1977","unstructured":"Blum CB, Levy RI, Eisenberg S, et al.: High density lipoprotein metabolism in man. J Clin Invest 1977, 60:795\u2013807.","journal-title":"J Clin Invest"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI109385","volume":"63","author":"J. Shepherd","year":"1979","unstructured":"Shepherd J, Packard CJ, Patsch JR, et al.: Effect of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism, J Clin Invest 1979, 63:858\u2013867.","journal-title":"J Clin Invest"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.17.10.2020","volume":"17","author":"F.Y. Jin","year":"1997","unstructured":"Jin FY, Kamanna VS, Kashyap ML: Niacin decreases removal of high density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implications for reverse cholesterol transport. Arterioscler Thromb Vasc Biol 1997, 17:2020\u20132028.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S. Acton","year":"1996","unstructured":"Acton S, Riggoti A, Landschutz KT, et al.: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518\u2013520.","journal-title":"Science"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","volume":"421","author":"L.O. Martinez","year":"2003","unstructured":"Martinez LO, Jacquet S, Esteve JP, et al.: Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003, 421:75\u201379.","journal-title":"Nature"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1194\/jlr.M700426-JLR200","volume":"49","author":"L.H. Zhang","year":"2008","unstructured":"Zhang LH, Kamanna VS, Zhang MC, Kashyap ML: Niacin inhibits surface expression of beta chain ATP synthase in HepG2 cells. Implications for rasing HDL. J Lipid Res 2008, 49:1195\u20131201.","journal-title":"J Lipid Res"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","volume":"67","author":"T. Rubic","year":"2004","unstructured":"Rubic T, Trottmann M, Lorenz RL: Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol 2004, 67:411\u2013419.","journal-title":"Biochem Pharmacol"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","volume":"9","author":"S. Tunaru","year":"2003","unstructured":"Tunaru S, Kero J, Schaub A, et al.: PUMA-G and HM74 are receptor for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003, 9:352\u2013355.","journal-title":"Nat Med"},{"key":"7_CR33","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","volume":"278","author":"A. Wise","year":"2003","unstructured":"Wise A, Foord SM, Fraser NJ, et al.: Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003, 278:9869\u20139874.","journal-title":"J Biol Chem"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","volume":"303","author":"T. Soga","year":"2003","unstructured":"Soga T, Kamohara M, Takasaki J, et al.: Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun 2003, 303:364\u2013369.","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","volume":"38","author":"J.D. Morrow","year":"1989","unstructured":"Morrow JD, Parsons WG 3rd, Roberts LJ 2nd.: Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 1989, 38:263\u2013274.","journal-title":"Prostaglandins"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","volume":"70","author":"Z. Benyo","year":"2006","unstructured":"Benyo Z, Gille A, Bennett CL, et al.: Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells. Mol Pharmacol 2006, 70:1844\u20131849.","journal-title":"Mol Pharmacol"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","volume":"126","author":"D. Maciejewski-Lenoir","year":"2006","unstructured":"Maciejewski-Lenoir D, Richman JG, Hakak Y, et al.: Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006, 126:2637\u20132646.","journal-title":"J Invest Dermatol"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2006.07.014","volume":"192","author":"C.D. Meyers","year":"2007","unstructured":"Meyers CD, Liu P, Kamanna VS, Kashyap ML: Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis 2007, 192:253\u2013258.","journal-title":"Atherosclerosis"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","volume":"115","author":"Z. Benyo","year":"2005","unstructured":"Benyo Z, Gille A, Kero J, et al.: GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005, 115:3634\u20133640.","journal-title":"J Clin Invest"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","volume":"103","author":"K. Cheng","year":"2006","unstructured":"Cheng K, Wu TJ, Sturino C, et al.: Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A 2006, 103:6682\u20136687.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1993.tb00649.x","volume":"233","author":"E.L. Jacobson","year":"1993","unstructured":"Jacobson EL, Jacobson MK: A biomarker for the assessment of niacin nutriture as a potential preventive factor in carcinogenesis. J Intern Med 1993, 233:59\u201362.","journal-title":"J Intern Med"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bbrc.1999.0154","volume":"255","author":"Q. Yan","year":"1999","unstructured":"Yan Q, Briehl M, Crowley CL, et al.: The NAD+ precursors, nicotinic acid and nicotinamide upregulate glyceraldehydes-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun 1999, 255:133\u2013136.","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR43","doi-asserted-by":"crossref","unstructured":"Ganji SH, Qin S, Zhang L, et al.: Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 2008 (in press)","DOI":"10.1016\/j.atherosclerosis.2008.04.044"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2007.07.008","volume":"1","author":"C.S. Vaccari","year":"2007","unstructured":"Vaccari CS, Hammoud RA, Nagamia SH, et al.: Revisiting niacin: reviewing the evidence. J Clin Lipidol 2007, 1:248\u2013255.","journal-title":"J Clin Lipidol"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5414\/CPP44633","volume":"44","author":"E.A. Cefali","year":"2006","unstructured":"Cefali EA, Simmons PD, Stanek EJ, et al.: Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. Int J Clin Pharmacol Ther 2006, 44:633\u2013640.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"7_CR46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP45078","volume":"45","author":"E.A. Cefali","year":"2007","unstructured":"Cefali EA, Simmons PD, Stanek EJ, et al.: Aspirin reduces cutaneous flushing after administration of an optimized extended-released niacin formulation. Int J Clin Pharmacol Ther 2007, 45:78\u201388.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"7_CR47","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","volume":"103","author":"K. Cheng","year":"2006","unstructured":"Cheng K, Wu T, Wu KK, et al.: Antagonism of the prostaglandin D2 receptor1 supresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A 2006, 103:6682\u20136687.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","volume":"81","author":"E. Lai","year":"2007","unstructured":"Lai E, DeLepepeire I, Crumley TM, et al.: Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther 2007, 81:849\u2013857.","journal-title":"Clin Pharmacol Ther"},{"key":"7_CR49","unstructured":"MacCubin D, Sirah W, Betteridge A, et al.: Flushing profile of ER niacin\/laropiprant in patients with primary hypercholesterolemia or mixed dyslipidemia. Poster presented at: 2007 AHA Scientific Sessions; November 4\u20137, 2007; Orlando, FL."}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-009-0007-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-009-0007-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-009-0007-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T01:20:35Z","timestamp":1632792035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-009-0007-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s11883-009-0007-9","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,17]]}}}